HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta Beauty Leadership Offers 2023 Holiday Outlook, AI Update In Q3 Earnings Call

Executive Summary

The US’ biggest beauty retailer is targeting fiscal 2023 net sales between $11.1bn and $11.15bn, with comparable sales growth of 5% to 5.5%, and is optimistic about 2024 and longer-term strategies. CEO David Kimbell addressed analyst questions on the 2023 holiday season, AI and other points of interest during the firm’s third-quarter earnings call.

You may also be interested in...



Ulta Expanding Its Youth-Targeted Luxe Platform, Exclusive Prestige Beauty Offerings

Ulta Beauty will add to its Ulta-only collections in the fiscal 2023 third quarter, bringing on cosmetics brands developed by the founders of Too Faced and Puig’s Paco Rabanne, while growing its new luxe beauty platform, installed in 200 stores so far. Net sales in the second quarter rose 10%.

L’Oreal’s Consumer Products, Dermatological Divisions In ‘Hyperdrive’; H1 Sales Leap 13%

L’Oreal’s organic top-line growth has been 8.2% on a compound annual basis since the start of 2019. The beauty giant’s overall net sales totaled roughly 3.74bn for the first half of 2023, an increase of 13.3% like-for-like, reflecting outstanding, broad-based performances across the business.

Ulta Beauty Will Have New CEO, Target Store Presence In Climb Back To 2019 Top Line

The specialty retailer, entering Target stores in the fall, is aiming for net sales of $7.2bn to $7.3bn in fiscal 2021, compared with $6.15bn in 2020 and $7.4bn in 2019. President Dave Kimbell will be taking the helm in June while CEO Mary Dillon stays on for one year as executive chair of the board.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel